Alterations in apoptosis regulatory factors during hypertrophy and heart failure
- PMID: 15001440
- DOI: 10.1152/ajpheart.00556.2003
Alterations in apoptosis regulatory factors during hypertrophy and heart failure
Abstract
Cardiac hypertrophy from pathological stimuli often proceeds to heart failure, whereas cardiac hypertrophy from physiological stimuli does not. In this study, physiological hypertrophy was created by a daily exercise regimen and pathological hypertrophy was created from a high-salt diet in Dahl salt-sensitive rats. The rats continued on a high-salt diet progressed to heart failure associated with an increased rate of terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling-positive cardiomyocytes. We analyzed primary cultures of these hearts and found that only cardiomyocytes made hypertrophic by a pathological stimulus show increased sensitivity to apoptosis. Examination of the molecular changes associated with these distinct types of hypertrophy revealed changes in Bcl-2 family members and caspases favoring survival during physiological hypertrophy. However, in pathological hypertrophy, there were more diffuse proapoptotic changes, including changes in Fas, the Bcl-2 protein family, and caspases. Therefore, we speculate that this increased sensitivity to apoptotic stimulation along with proapoptotic changes in the apoptosis program may contribute to the development of heart failure seen in pathological cardiac hypertrophy.
Similar articles
-
Multisite phosphorylation of Bcl-2 via protein kinase Cδ facilitates apoptosis of hypertrophic cardiomyocytes.Clin Exp Pharmacol Physiol. 2014 Nov;41(11):891-901. doi: 10.1111/1440-1681.12295. Clin Exp Pharmacol Physiol. 2014. PMID: 25132161
-
Relationship between cardiomyocyte cell death and cardiac function during hypertensive cardiac remodelling in Dahl rats.Clin Sci (Lond). 2002 Mar;102(3):329-35. Clin Sci (Lond). 2002. PMID: 11869174
-
Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.Circ Res. 2003 Jul 11;93(1):12-22. doi: 10.1161/01.RES.0000079794.57578.F1. Epub 2003 Jun 5. Circ Res. 2003. PMID: 12791704
-
Structural pathways and prevention of heart failure and sudden death.J Cardiovasc Electrophysiol. 2003 Jul;14(7):764-75. doi: 10.1046/j.1540-8167.2003.02543.x. J Cardiovasc Electrophysiol. 2003. PMID: 12930259 Review.
-
Does load-induced ventricular hypertrophy progress to systolic heart failure?Am J Physiol Heart Circ Physiol. 2005 Jul;289(1):H8-H16. doi: 10.1152/ajpheart.01303.2004. Am J Physiol Heart Circ Physiol. 2005. PMID: 15961379 Review.
Cited by
-
Role of AIF in cardiac apoptosis in hypertrophic cardiomyocytes from Dahl salt-sensitive rats.Cardiovasc Res. 2010 Jan 1;85(1):28-37. doi: 10.1093/cvr/cvp261. Cardiovasc Res. 2010. PMID: 19633014 Free PMC article.
-
Exercise for the heart: signaling pathways.Oncotarget. 2015 Aug 28;6(25):20773-84. doi: 10.18632/oncotarget.4770. Oncotarget. 2015. PMID: 26318584 Free PMC article. Review.
-
Mechanisms of exercise-induced cardioprotection.Physiology (Bethesda). 2014 Jan;29(1):27-38. doi: 10.1152/physiol.00030.2013. Physiology (Bethesda). 2014. PMID: 24382869 Free PMC article. Review.
-
Endothelin A receptor antagonist, atrasentan, attenuates renal and cardiac dysfunction in Dahl salt-hypertensive rats in a blood pressure independent manner.PLoS One. 2015 Mar 16;10(3):e0121664. doi: 10.1371/journal.pone.0121664. eCollection 2015. PLoS One. 2015. PMID: 25775254 Free PMC article.
-
Pregestational type 2 diabetes mellitus induces cardiac hypertrophy in the murine embryo through cardiac remodeling and fibrosis.Am J Obstet Gynecol. 2017 Aug;217(2):216.e1-216.e13. doi: 10.1016/j.ajog.2017.04.008. Epub 2017 Apr 13. Am J Obstet Gynecol. 2017. PMID: 28412087 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
